胃癌晚期,不能手术“等死”?医生这样救了她

2018-04-20 李东/上海交通大学医学院附属瑞金医院 澎湃新闻

今天是42岁的赵春梅出院的日子,几个月前因查出胃癌而被宣告不治的她,在瑞金专家的精准方案下明显好转,此刻正高兴地指挥着丈夫老陈上下收拾回家的行囊。几年前,赵春梅(化名)发现自己饭后总是胃胀、反酸。慢慢的,她开始吃不下饭了,人暴瘦了10多斤。上腹严重的胀痛让一向自诩身强体壮的她扛不住了,去年十一在海门当地做了个胃镜。“胃黏膜增厚”,看到这五个字时,丈夫老陈的心上咯噔一声,意识到这或许不是个好兆

今天是42岁的赵春梅出院的日子,几个月前因查出胃癌而被宣告不治的她,在瑞金专家的精准方案下明显好转,此刻正高兴地指挥着丈夫老陈上下收拾回家的行囊。

几年前,赵春梅(化名)发现自己饭后总是胃胀、反酸。慢慢的,她开始吃不下饭了,人暴瘦了10多斤。上腹严重的胀痛让一向自诩身强体壮的她扛不住了,去年十一在海门当地做了个胃镜。

“胃黏膜增厚”,看到这五个字时,丈夫老陈的心上咯噔一声,意识到这或许不是个好兆头,但他不敢往下想,悄悄的把检查报告掖进口袋,强装笑意的跟赵春梅说“别担心,估计就是小胃病,咱好好吃药就好了”。

“这种情况,最多三个月”

挂了一个星期的盐水,赵春梅的情况一点不见好转。老陈急了,“不行,马上去上海!”

来到上海,在外院被安排剖腹探查手术,但一切似乎都迟了:划开肚子,只见原本松软的胃壁“爬”满肿瘤,变得坚硬无比。更要命的是,肿瘤已发生多处扩散,无法手术根除,只能关腹。

之后,老陈带着赵春梅跑了3家三甲医院,听了一遍又一遍:“这种情况,最多三个月。”最绝望时,老陈躲在卫生间里,手捂着眼睛,呜咽着:为什么发生在你身上……

但很快调整好状态的他转头又安抚着电话那头放心不下的儿子,“妈妈精神好得很,你安心念书,我们很快就回去了”。抱着最后的希望,老陈推着轮椅上的老婆来到瑞金医院。

“可以的,我们一起试试看。”最终接诊赵春梅的是瑞金医院肿瘤科主任张俊,一个在其导师、国内著名胃肠外科专家朱正纲教授培养下与胃肠、胆胰肿瘤斗争的高手,他秉承了瑞金胃癌课题组重视临床科研并举的传统,擅长排兵布阵,用最适合的方式,抑制住肿瘤。

经过一系列检查结合外院报告,赵春梅最终被确诊为胃部低分化腺癌Ⅳ期(晚期)。这是一种早期无明显症状,但出现症状时多为中晚期的胃癌。

任何一个基于肿瘤的治疗,都是基于全面评估的基础上。“胃癌术前分期CT,能精准评估肿瘤的侵犯程度,这正是我们瑞金的王牌,也是全上海独一家。”张俊解释说,因为明确的细化指标,能够精准地协助医生判断肿瘤期别,有助于医生做临床决策。

在最正确的时间,寻找最合适的方案

“现在对肿瘤的治疗已经不是上来就开刀,或者拉起来就化疗。”张俊表示,妥善评估后,下一步就是要精准定位,在最正确的时间,寻找最合适的方案,这也是MDT(多学科团队)的意义所在。

1月30日下午,胃癌MDT诊室内集齐了外科、肿瘤内科、放疗治疗科、放射诊断科、中医科、消化内科、病理科、营养科等8大科室的专家,围绕赵春梅的病例开展热烈的讨论。

14:00,管床医生肿瘤科施敏通过PPT投影介绍赵春梅的基本情况、主诉、病史、各项检查结果,以及会诊诉求。

放射科张欢主任通过胃癌术前分期CT评估,证实诊断结果:患者全胃弥漫性的病灶,且有多处病灶转移,考虑为“皮革胃”。

外科朱正伦主治医生补充说:“病人在外院刚做过开腹手术,分期为晚期胃癌,单纯靠手术是很难解决问题的,应考虑为病人争取综合治疗机会。”

放疗科蔡钢副主任医师立即接道,不能确定腹膜转移的风险,放疗指征不明确,建议全身化疗为主,有必要的话再考虑放疗。

有得聊,一定程度上说明张俊的判断没错,“患者还有治疗机会”。

大家达成一致意见:由于病人HER2基因为阴性,不适合做靶向治疗,最终选定静脉紫杉醇联合口服替吉奥的联合化疗方案。

“有的肿瘤长得快,有的肿瘤很调皮。治疗肿瘤的方案怎么选,全部就在审时度势的博弈中”。张俊介绍说,治疗肿瘤无外乎三种方法:首先开刀移掉;没法移掉,就用放疗或射频消融等方法进行结构上的毁损;第三,靠药物抑制肿瘤生长。

延长生命,是最好的恩赐

第四个疗程结束,赵春梅的病情明显好转了——治疗方向对了!

“肿瘤标志物CA125明显下降,同时影像报告显示,病灶明显缩小。”趁着春节,丈夫老陈组织全家人一起去安徽石台旅行,看看山水,呼吸新鲜空气,这一趟回来赵春梅的心里更有力量了。

要想根治肿瘤,手术是唯一的方法。经过胃肠肿瘤MDT第二次讨论,3月2日在胃肠外科施行了根治性远端胃大部切除术,手术非常顺利。

而最让医生高兴的是,肿瘤比CT成像退缩的更好,除了黏膜下少量癌细胞残留,没有远处转移!

病房里,特地赶来的施敏医生正叮嘱赵春梅术后随访事宜,她认真听、认真记,忍不住再三确认。“从只能‘回家等死’,到几个月后又‘起死回生’了,我的命运完完全全改变了。” 赵春梅满含热泪地说,而她更想告诉那些走投无路的患者——在瑞金,真的可以给你带来希望。

除在医院接受的治疗外,瑞金医院肿瘤科推行并普及了“肿瘤居家看护理念”,即通过《肿瘤居家疗法》书籍、微信公众号、微博、随身护士小软件等一系列患教举措,维护肿瘤患者治疗期间居家疗养的生活质量、家庭角色与社会功能。

重心前移,胃肠道肿瘤是可防可治的

2015年,全球新增100万例胃癌患者,中国占42%。这数字每年这样僵持着。目前,胃癌在我国各类肿瘤的发病率和死亡率都已排名第二。

“我们的问题是胃癌早期病例太少,仅占10%左右,也就是说90%新发现的胃癌都到了中晚期。”

因为早期诊断率还不高,大量病人拖到了晚期才被发现。张俊说,早期胃癌往往没有症状,但这类患者手术后的生存期和生活质量都非常好。

他强调,胃肠道肿瘤早癌的筛查,只有通过内镜检查。过去对癌症,注重后期治疗,而轻视前期诊断,现在就是要把关口前移至诊断阶段。这也提示,年龄大于40岁有腹痛、腹胀等不适症状,并有慢性胃炎、胃息肉、慢性胃溃疡等病变及有肿瘤家族史的对象,应根据医生建议定期做胃镜检查。

胃癌高危人群

1、60岁以上人群;

2、中重度萎缩性胃炎;

3、慢性胃溃疡;

4、胃息肉;

5、良性疾病术后残胃(术后10年);

6、胃癌术后残胃(术后6~12月);

7、异型增生(轻、中、重);

8、中、重度肠化生;

9、明确家族史;

10、胃黏膜巨大皱褶征。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-23 zb1235672

    好知识值得拥有

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-23 121832a9m88暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-22 一天没事干

    晚期癌症.提高生活质量为主.缓解病人痛苦为主

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-22 cscdliu

    学习了.谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 秀红

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 871538379

    最后一段非常好 学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=308628, encodeId=77a430862831, content=好知识值得拥有, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=59321624668, createdName=zb1235672, createdTime=Mon Apr 23 21:05:19 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308364, encodeId=7ee5308364dc, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 23 05:20:18 CST 2018, time=2018-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308280, encodeId=d53c3082806c, content=晚期癌症.提高生活质量为主.缓解病人痛苦为主, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/04/12/cd30eefc465f70dc4dad89bd57479781.jpg, createdBy=02be2318568, createdName=一天没事干, createdTime=Sun Apr 22 17:48:53 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308253, encodeId=7c5a3082537b, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/557c1f19aaf5459a8405411e38903c4b.jpg, createdBy=dfc02088287, createdName=cscdliu, createdTime=Sun Apr 22 14:09:50 CST 2018, time=2018-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307904, encodeId=5d5930e90432, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/15/8213228fe923915543544ad3da7e1c64.jpg, createdBy=6bd82014262, createdName=秀红, createdTime=Sat Apr 21 11:53:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307764, encodeId=3bbc30e76491, content=最后一段非常好 学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Sat Apr 21 06:09:34 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307726, encodeId=44b230e726dc, content=学习了很有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Sat Apr 21 00:11:27 CST 2018, time=2018-04-21, status=1, ipAttribution=)]
    2018-04-21 飛歌

    学习了很有用

    0

相关资讯

Cell Death Dis:发现肿瘤相关巨噬细胞促进胃癌转移新机制

近日,来自上海交通大学医学院附属新华医院检验科沈立松课题组的研究人员在胃癌的发病机制方面取得了新的进展,明确了肿瘤相关巨噬细胞来源的外泌体对胃癌转移的影响,发现M2型巨噬细胞亚群通过外泌体传递ApoE蛋白分子促进胃癌细胞的迁移及转移过程。该成果发表在最新一期的Cell Death & Disease 杂志上。

Stem cells:PGD2/PTGDR2信号可抑制胃癌细胞进行自我更新,为控制胃癌进展提供新的思路

已知前列腺素D2(PGD2)对胃癌(GC)具有抗肿瘤作用已有十余年。但是,PGD2's对GC生长的控制机制尚未明确。癌症干细胞(CSCs)与肿瘤新生血管形成、侵袭性和治疗耐受性相关。近期研究人员发现PGD2与其受体(PTGDR2)之间的信号,在体外可抑制GC细胞的自我更新,在体内可抑制肿瘤增长转移。GC组织中PGD2合成酶(L-PTGDS)和PTGDR2表达水平明显低于邻近正常组织,并与患者预后相

河南研究:有这三个生活习惯者易患胃癌

饮食因素是肿瘤发生发展的重要因素。据河南省肿瘤医院河南省肿瘤防治研究办公室发表的研究,油炸食品是胃癌及癌前病变发生的危险因素。

Gastroenterology:幽门螺杆菌感染根除对降低老年患者胃癌风险效果显著

研究认为,幽门螺杆菌感染根除对降低胃癌风险的效果显著,特别是对于老年人群以及尽早开展根除治疗的患者

JAMA Oncol:Pembrolizumab为晚期胃或胃食管交界部腺癌三线治疗带来新希望

晚期胃癌目前缺乏标准的三线治疗方案。KEYNOTE-059研究评估了Pembrolizumab单药用于经治的晚期胃癌或胃食管交界部癌三线或以上治疗的疗效和安全性。目前研究的初步结果发表在《JAMA Oncology》杂志。

ANN SURG:腹腔腹与开腹远端胃癌D2根治术对比

D2淋巴结清扫是晚期胃癌的标准治疗方案。尽管腹腔镜辅助远端胃切除在早期胃癌治疗中已得到广泛应用,其在晚期胃癌中的可行性尚未得到证实。ANN SURG近期发表了一篇文章,评估了腹腔镜辅助远端胃切除术联合D2淋巴结清扫与开腹远端胃切除术对比治疗晚期胃癌的效果。